Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of prematuration culture with a phosphodiesterase-3 inhibitor on oocyte morphology and embryo quality in in vitro maturation

  • Received : 2021.02.08
  • Accepted : 2021.05.25
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The study assessed the developmental potential of germinal vesicle (GV) oocytes subjected to in vitro maturation (IVM) after prematuration culture with cilostamide (a phosphodiesterase-3 inhibitor) and the impact of cilostamide exposure on the morphology of meiosis II (MII) oocytes and subsequent embryo quality. Methods: In total, 994 oocytes were collected from 63 patients. Among 307 GV oocytes, 140 oocytes were selected for the experimental group and 130 oocytes for the control group. The denuded GV-stage oocytes were cultured for 6 hours with cilostamide in the experimental group and without cilostamide in the control group. After 6 hours, the oocytes in the experimental group were washed and transferred to fresh IVM medium. The maturational status of the oocytes in both groups was examined at 26, 36, and 48 hours. Fertilization was assessed at 18 hours post-intracytoplasmic sperm injection. Embryo quality was assessed on days 3 and 5. Results: In total, 92.1% of the oocytes remained in the GV stage, while 6.4% converted to the MI stage (p<0.01) after cilostamide exposure. In both groups, more MII oocytes were observed at 36 hours (25.8% vs. 21.5%) than at 26 hours (10.8% vs. 14.6%) and 48 hours (13% vs. 7.9%) (p>0.05). With the advent of cilostamide, blastocyst quality was better in the experimental group than in the control group (p<0.05). Conclusion: Cilostamide effectively blocked nuclear maturation and promoted cytoplasmic growth. Prematuration culture with cilostamide enabled synchronization between cytoplasmic and nuclear maturity, resulting in better blastocyst outcomes.

Keywords

Acknowledgement

We thank Dr. Mir Jaffar, Scientific Director, Milann Fertility Center, India for critical advice on this manuscript.

References

  1. Cha KY, Chian RC. Maturation in vitro of immature human oocytes for clinical use. Hum Reprod Update 1998;4:103-20. https://doi.org/10.1093/humupd/4.2.103
  2. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril 2013;99:663-6. https://doi.org/10.1016/j.fertnstert.2012.12.031
  3. U.S. Department of Health and Human Services Centers for Disease Control and Prevention. 2005 Assisted reproductive technology success rates: National summary and fertility clinic reports. Atlanta: U.S: Department of Health and Human Services Centers for Disease Control and Prevention; 2007.
  4. Moor RM, Dai Y, Lee C, Fulka J Jr. Oocyte maturation and embryonic failure. Hum Reprod Update 1998;4:223-36. https://doi.org/10.1093/humupd/4.3.223
  5. Pan B, Li J. The art of oocyte meiotic arrest regulation. Reprod Biol Endocrinol 2019;17:1-12. https://doi.org/10.1186/s12958-018-0446-7
  6. Bassham S, Canestro C, Postlethwait JH. Evolution of developmental roles of Pax2/5/8 paralogs after independent duplication in urochordate and vertebrate lineages. BMC Biol 2008;6:35. https://doi.org/10.1186/1741-7007-6-35
  7. Combelles CM, Cekleniak NA, Racowsky C, Albertini DF. Assessment of nuclear and cytoplasmic maturation in in-vitro matured human oocytes. Hum Reprod 2002;17:1006-16. https://doi.org/10.1093/humrep/17.4.1006
  8. Conti M, Andersen CB, Richard FJ, Shitsukawa K, Tsafriri A. Role of cyclic nucleotide phosphodiesterases in resumption of meiosis. Mol Cell Endocrinol 1998;145:9-14. https://doi.org/10.1016/S0303-7207(98)00187-7
  9. Son WY, Chung JT, Demirtas E, Holzer H, Sylvestre C, Buckett W, et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod Biomed Online 2008;17:59-67. https://doi.org/10.1016/S1472-6483(10)60294-5
  10. Ferrell JE Jr. Xenopus oocyte maturation: new lessons from a good egg. Bioessays 1999;21:833-42. https://doi.org/10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P
  11. Taieb F, Thibier C, Jessus C. On cyclins, oocytes, and eggs. Mol Reprod Dev 1997;48:397-411. https://doi.org/10.1002/(SICI)1098-2795(199711)48:3<397::AID-MRD14>3.0.CO;2-T
  12. Gardner DK, Weissman A, Howles CM, Shoham Z. Textbook of assisted reproductive technologies: laboratory and clinical perspectives. Boca Raton: CRC Press; 2008.
  13. Shu Y, Gebhardt J, Watt J, Lyon J, Dasig D, Behr B. Fertilization, embryo development, and clinical outcome of immature oocytes from stimulated intracytoplasmic sperm injection cycles. Fertil Steril 2007;87:1022-7. https://doi.org/10.1016/j.fertnstert.2006.08.110
  14. Alvarez C, Garcia-Garrido C, Taronger R, Gonzalez de Merlo G. In vitro maturation, fertilization, embryo development & clinical outcome of human metaphase-I oocytes retrieved from stimulated intracytoplasmic sperm injection cycles. Indian J Med Res 2013;137:331-8.
  15. Guimaraes AL, Pereira SA, Kussano NR, Dode MA. The effect of pre-maturation culture using phosphodiesterase type 3 inhibitor and insulin, transferrin and selenium on nuclear and cytoplasmic maturation of bovine oocytes. Zygote 2016;24:219-29. https://doi.org/10.1017/S0967199415000064
  16. Hardy K, Wright CS, Franks S, Winston RM. In vitro maturation of oocytes. Br Med Bull 2000;56:588-602. https://doi.org/10.1258/0007142001903391
  17. Tsafriri A, Chun SY, Zhang R, Hsueh AJ, Conti M. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol 1996;178:393-402. https://doi.org/10.1006/dbio.1996.0226
  18. Wiersma A, Hirsch B, Tsafriri A, Hanssen RG, Van de Kant M, Kloosterboer HJ, et al. Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents. J Clin Invest 1998;102:532-7. https://doi.org/10.1172/JCI2566
  19. Conti M, Andersen CB, Richard F, Mehats C, Chun SY, Horner K, et al. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol 2002;187:153-9. https://doi.org/10.1016/S0303-7207(01)00686-4
  20. Jee BC, Chen HY, Chian RC. Effect of a phosphodiesterase type 3 inhibitor in oocyte maturation medium on subsequent mouse embryo development. Fertil Steril 2009;91(5 Suppl):2037-42. https://doi.org/10.1016/j.fertnstert.2008.03.041
  21. Malvezzi H, Sharma R, Agarwal A, Abuzenadah AM, Abu-Elmagd M. Sperm quality after density gradient centrifugation with three commercially available media: a controlled trial. Reprod Biol Endocrinol 2014;12:121. https://doi.org/10.1186/1477-7827-12-121
  22. Xue X, Wang WS, Shi JZ, Zhang SL, Zhao WQ, Shi WH, et al. Efficacy of swim-up versus density gradient centrifugation in improving sperm deformity rate and DNA fragmentation index in semen samples from teratozoospermic patients. J Assist Reprod Genet 2014;31:1161-6. https://doi.org/10.1007/s10815-014-0287-z
  23. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 2011;26:1270-83. https://doi.org/10.1093/humrep/der037
  24. Xu KP, Greve T, Smith S, Hyttel P. Chronological changes of bovine follicular oocyte maturation in vitro. Acta Vet Scand 1986;27:505-19. https://doi.org/10.1186/BF03548130
  25. Ponderato N, Crotti G, Turini P, Duchi R, Galli C, Lazzari G. Embryonic and foetal development of bovine oocytes treated with a combination of butyrolactone I and roscovitine in an enriched medium prior to IVM and IVF. Mol Reprod Dev 2002;62:513-8. https://doi.org/10.1002/mrd.10134
  26. DiLuigi A, Weitzman VN, Pace MC, Siano LJ, Maier D, Mehlmann LM. Meiotic arrest in human oocytes is maintained by a Gs signaling pathway. Biol Reprod 2008;78:667-72. https://doi.org/10.1095/biolreprod.107.066019
  27. Shu YM, Zeng HT, Ren Z, Zhuang GL, Liang XY, Shen HW, et al. Effects of cilostamide and forskolin on the meiotic resumption and embryonic development of immature human oocytes. Hum Reprod 2008;23:504-13. https://doi.org/10.1093/humrep/dem344
  28. Jaffe LA, Egbert JR. Regulation of mammalian oocyte meiosis by intercellular communication within the ovarian follicle. Annu Rev Physiol 2017;79:237-60. https://doi.org/10.1146/annurev-physiol-022516-034102
  29. Adona PR, Lima Verde Leal C. Meiotic inhibition with different cyclin-dependent kinase inhibitors in bovine oocytes and its effects on maturation and embryo development. Zygote 2004;12:197-204. https://doi.org/10.1017/s0967199404002771
  30. Tatemoto H, Terada T. Time-dependent effects of cycloheximide and alpha-amanitin on meiotic resumption and progression in bovine follicular oocytes. Theriogenology 1995;43:1107-13. https://doi.org/10.1016/0093-691X(95)00074-I
  31. Kim BK, Lee SC, Kim KJ, Han CH, Kim JH. In vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles. Fertil Steril 2000;74:1153-8. https://doi.org/10.1016/S0015-0282(00)01617-4
  32. Nogueira D, Cortvrindt R, De Matos DG, Vanhoutte L, Smitz J. Effect of phosphodiesterase type 3 inhibitor on developmental competence of immature mouse oocytes in vitro. Biol Reprod 2003;69:2045-52. https://doi.org/10.1095/biolreprod.103.021105
  33. Ola SI, Wang Q, Ai JS, Yin S, Liang CG, Chen DY, et al. Meiotic competence and acetylation pattern of UV light classified mouse antral oocytes after meiotic arrest with isobutylmethylxanthine. Mol Reprod Dev 2007;74:591-9. https://doi.org/10.1002/mrd.20625
  34. De La Fuente R, Eppig JJ. Transcriptional activity of the mouse oocyte genome: companion granulosa cells modulate transcription and chromatin remodeling. Dev Biol 2001;229:224-36. https://doi.org/10.1006/dbio.2000.9947
  35. Vanhoutte L, De Sutter P, Nogueira D, Gerris J, Dhont M, Van der Elst J. Nuclear and cytoplasmic maturation of in vitro matured human oocytes after temporary nuclear arrest by phosphodiesterase 3-inhibitor. Hum Reprod 2007;22:1239-46. https://doi.org/10.1093/humrep/dem007
  36. Son W, Chung J, Cui S, Dean N, Tan S, Chian R. P-704: comparison of embryology and clinical outcome between IVM cycles with and without mature oocytes collected following HCG priming. Fertil Steril 2006;86:S394-S5.
  37. Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 2007;105:542-4. https://doi.org/10.1016/j.ygyno.2007.01.036
  38. Son WY, Lee SY, Lim JH. Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles. Hum Reprod 2005;20:3204-7. https://doi.org/10.1093/humrep/dei195
  39. Dekel N, Lawrence TS, Gilula NB, Beers WH. Modulation of cell-tocell communication in the cumulus-oocyte complex and the regulation of oocyte maturation by LH. Dev Biol 1981;86:356-62. https://doi.org/10.1016/0012-1606(81)90193-7
  40. Xie HL, Wang YB, Jiao GZ, Kong DL, Li Q, Li H, et al. Effects of glucose metabolism during in vitro maturation on cytoplasmic maturation of mouse oocytes. Sci Rep 2016;6:20764. https://doi.org/10.1038/srep20764
  41. Hyttel P, Callesen H, Greve T. Ultrastructural features of preovulatory oocyte maturation in superovulated cattle. J Reprod Fertil 1986;76:645-56. https://doi.org/10.1530/jrf.0.0760645